ACRS vs VRTX: Which Stock is Better?

Side-by-side comparison of Aclaris Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

ACRS

Aclaris Therapeutics Inc

$4.43

VRTX

Vertex Pharmaceuticals Inc

$442.08

Key Metrics Comparison

MetricACRSVRTXWinner
Market Cap$283.86M$113.16BVRTX
P/E RatioN/A31.06VRTX
EPS (TTM)$N/A$14.21VRTX
Revenue Growth-0.2%0.1%VRTX
Gross Margin-275.7%52.7%VRTX

Analyze ACRS

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACRS or VRTX a better investment?

Comparing ACRS and VRTX: Aclaris Therapeutics Inc has a market cap of $283.86M while Vertex Pharmaceuticals Inc has $113.16B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACRS and VRTX?

ACRS (Aclaris Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACRS or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ACRS or VRTX?

VRTX has higher revenue growth at 0.1% vs -0.2% for ACRS.

Which company is more profitable: ACRS or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 52.7% compared to -275.7% for ACRS.

Which is the larger company: ACRS or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.16B compared to $283.86M for ACRS.

Should I buy ACRS or VRTX in 2026?

Both ACRS and VRTX have investment merit. ACRS trades at $4.43 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACRS and VRTX stock?

Key differences: Market Cap ($283.86M vs $113.16B), P/E Ratio (N/A vs 31.1x), Revenue Growth (-0.2% vs 0.1%), Gross Margin (-275.7% vs 52.7%).

Popular Stock Comparisons